0001209191-13-050999.txt : 20131106 0001209191-13-050999.hdr.sgml : 20131106 20131106162539 ACCESSION NUMBER: 0001209191-13-050999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131104 FILED AS OF DATE: 20131106 DATE AS OF CHANGE: 20131106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 131196782 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-11-04 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 SVP & Corp Controller Common Stock 2013-11-04 4 M 0 937 39.05 A 12687 D Common Stock 2013-11-04 4 M 0 937 38.80 A 13624 D Common Stock 2013-11-04 4 M 0 1125 37.86 A 14749 D Common Stock 2013-11-04 4 S 0 1858 66.64 D 12891 D Common Stock 2013-11-04 4 S 0 1141 67.22 D 11750 D Common Stock 169 I 401(k) Stock Option (right to buy) 39.05 2013-11-04 4 M 0 937 0.00 D 2020-02-03 Common Stock 937 938 D Stock Option (right to buy) 38.80 2013-11-04 4 M 0 937 0.00 D 2021-02-02 Common Stock 937 4688 D Stock Option (right to buy) 37.86 2013-11-04 4 M 0 1125 0.00 D 2022-02-01 Common Stock 1125 10125 D Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $66.64 (range $66.30 to $66.99). Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $67.22 (range $67.00 to $67.38). The option vests in 16 quarterly installments from 2/4/2010. The option vests in 16 quarterly installments from 2/3/2011. The option vests in 16 quarterly installments from 2/2/2012. Kenneth L. Horton, Attorney-In-Fact 2013-11-06